Enoxaparin Sodium Injection,usp Injection, Solution
FDA Label NDC 0781-3482

69 label sections · Submitted to the FDA by Sandoz Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sandoz Inc. for the product Enoxaparin Sodium Injection, Usp (NDC 0781-3482). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: spinal/epidural hematomas, 1 indications and usage, 1.1 prophylaxis of deep vein thrombosis, 1.2 treatment of acute deep vein thrombosis, 1.3 prophylaxis of ischemic complications of unstable angina and non–q˗wave myocardial infarction, 1.4 treatment of acute st-segment elevation myocardial infarction, 2 dosage and administration, 2.1 pretreatment evaluation, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.